Zumla A - Search Results

1

Tuberculosis: amplification-based clinical diagnostic techniques.

Huggett JF, McHugh TD, Zumla A. Huggett JF, et al. Among authors: zumla a. Int J Biochem Cell Biol. 2003 Oct;35(10):1407-12. doi: 10.1016/s1357-2725(03)00102-x. Int J Biochem Cell Biol. 2003. PMID: 12818237 Review.

2

Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods.

Green C, Huggett JF, Talbot E, Mwaba P, Reither K, Zumla AI. Green C, et al. Lancet Infect Dis. 2009 Aug;9(8):505-11. doi: 10.1016/S1473-3099(09)70149-5. Lancet Infect Dis. 2009. PMID: 19628175 Review.

3

Implications of storing urinary DNA from different populations for molecular analyses.

Cannas A, Kalunga G, Green C, Calvo L, Katemangwe P, Reither K, Perkins MD, Maboko L, Hoelscher M, Talbot EA, Mwaba P, Zumla AI, Girardi E, Huggett JF; TB trDNA consortium. Cannas A, et al. Among authors: zumla ai. PLoS One. 2009 Sep 10;4(9):e6985. doi: 10.1371/journal.pone.0006985. PLoS One. 2009. PMID: 19746164 Free PMC article.

4

Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre.

Marks DJ, Hyams C, Koo CY, Pavlou M, Robbins J, Koo CS, Rodger G, Huggett JF, Yap J, Macrae MB, Swanton RH, Zumla AI, Miller RF. Marks DJ, et al. Among authors: zumla ai. QJM. 2015 Mar;108(3):219-29. doi: 10.1093/qjmed/hcu188. Epub 2014 Sep 15. QJM. 2015. PMID: 25223570

5

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

Zumla AI, Gillespie SH, Hoelscher M, Philips PP, Cole ST, Abubakar I, McHugh TD, Schito M, Maeurer M, Nunn AJ. Zumla AI, et al. Lancet Infect Dis. 2014 Apr;14(4):327-40. doi: 10.1016/S1473-3099(13)70328-1. Lancet Infect Dis. 2014. PMID: 24670627 Review.

6

Type 2 cytokines in respiratory syncytial virus bronchiolitis.

Dheda K, Huggett JF, Kim LU, Zumla A. Dheda K, et al. Among authors: zumla a. Am J Respir Crit Care Med. 2004 May 15;169(10):1167-8; author reply 1168. doi: 10.1164/ajrccm.169.10.958. Am J Respir Crit Care Med. 2004. PMID: 15132965 No abstract available.

7

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects.

Zumla A, Rao M, Wallis RS, Kaufmann SH, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M; Host-Directed Therapies Network consortium. Zumla A, et al. Lancet Infect Dis. 2016 Apr;16(4):e47-63. doi: 10.1016/S1473-3099(16)00078-5. Lancet Infect Dis. 2016. PMID: 27036359 Free PMC article. Review.

8

Tuberculosis.

Lawn SD, Zumla AI. Lawn SD, et al. Lancet. 2011 Jul 2;378(9785):57-72. doi: 10.1016/S0140-6736(10)62173-3. Epub 2011 Mar 21. Lancet. 2011. PMID: 21420161 Review.

9

Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines.

Zumla AI, Schito M, Maeurer M. Zumla AI, et al. Lancet Infect Dis. 2014 Apr;14(4):267-9. doi: 10.1016/S1473-3099(14)70028-3. Lancet Infect Dis. 2014. PMID: 24670623 No abstract available.

10

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Kaufmann SH, et al. Lancet Respir Med. 2014 Apr;2(4):301-20. doi: 10.1016/S2213-2600(14)70033-5. Epub 2014 Mar 24. Lancet Respir Med. 2014. PMID: 24717627 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

824 results

Search Page